ACTAVIS PLC Financials
moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here to view […]
ACT
Q4 Earnings Decline Y/Y at Endo, Weak Outlook
moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here to view […]
8:03 am Actavis confirms that it has filed an Abbreviated New Drug Application with the FDA seeking approval to market Dronedarone Hydrochloride Tablets 400 mg
moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here to view […]
Apple, Shire, CEB, NCAA, Lessig: Intellectual Property
moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here to view […]
Actavis confirms patent challenge on generic Colcrys
moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here to view […]
Actavis Confirms Generic Colcrys® Patent Challenge
[PR Newswire] – DUBLIN, Feb. 28, 2014 /PRNewswire/ — Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval … moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here […]
Sanofi sues Actavis over generic version of heart drug Multaq
[Reuters] – French pharmaceutical company Sanofi has filed a lawsuit against Actavis over alleged patent infringements on its heart drug Multaq, hindering the generic drugmaker’s plans to produce its own version of the drug. Multaq generated sales of 269 moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring […]
8:03 am Actavis confirms that it has filed an Abbreviated New Drug Application with the FDA seeking approval to market Dronedarone Hydrochloride Tablets 400 mg
moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here to view […]
Actavis Confirms Generic Multaq® Patent Challenge
[PR Newswire] – DUBLIN, Feb. 28, 2014 /PRNewswire/ — Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval … moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here […]
Can The Uptrend Continue for Actavis (ACT)?
moreView todays social media effects on ACTView the latest stocks trending across Twitter. Click to view dashboardSee who Actavis is hiring next, click here to view […]
